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Quantitative trait loci and genes 
associated with salmonid 
alphavirus load in Atlantic salmon: 
implications for pancreas disease 
resistance and tolerance
M. L. Aslam1, D. Robledo 2, A. Krasnov1, H. K. Moghadam3, B. Hillestad3, R. D. Houston2, 
M. Baranski4, S. Boison4 & n. A. Robinson1,5*
Salmonid alphavirus infection results in pancreas disease causing severe economic losses for 
Atlantic salmon aquaculture. Knowledge about genes and pathways contributing to resistance 
is limited. A 54 K SNP panel was used to genotype 10 full-sibling families each consisting of ~ 110 
offspring challenged with salmonid alphavirus subtype 3. Relative heart viral load was assessed at 
4- and 10-weeks post-infection using quantitative PCR. A moderate genomic heritability of viral 
load at 4 weeks (0.15–0.21) and a high positive correlation with survival (0.91–0.98) were detected. 
Positions of QTL detected on chromosome 3 matched those for survival detected by other studies. 
The SNP of highest significance occurred in the 3′ untranslated region of gig1, a fish-specific antiviral 
effector. Locus B of immunoglobulin heavy chain mapped to an area containing multiple SNPs with 
genome-wide association. Heart mRNA-seq comparing parr from families with high- versus low-
genomic breeding value, and matching sample genotypes for SNPs, identified two eQTL for salmonid 
alphavirus load. Immune genes associated with trans-eQTL were numerous and spread throughout 
the genome. QtL regions contained several genes with known or predicted immune functions, some 
differentially expressed. The putative functional genes and variants identified could help improve 
marker-based selection for pancreas disease resistance.
Infectious diseases are a major threat to the sustainability of Atlantic salmon farming, causing production and 
economic losses, and having a negative impact on fish welfare and the environment. One of the major disease 
problems in Atlantic salmon aquaculture is pancreas disease (PD), which affects mainly first year Atlantic salmon 
 smolts1–8. Mortality due to natural outbreaks of PD is variable, ranging from negligible up to 63%7,9–12. A Nor-
wegian cohort study (2006–2008) reported an average PD-associated mortality of ~ 6.9% (range 0.7–26.9%)13. 
However, economic losses due to morbidity can be high due to prolonged loss of appetite, growth retardation, 
and reduced filet  quality7,11. There have been several reports describing after-effects of PD outbreaks including 
the development of runts, and significantly lower growth in PD affected  fish11,14–16.
PD is caused by Salmonid alphavirus (SAV), an infectious single-stranded positive-sense RNA  virus17,18. The 
mode of the spread of infection of salmonid diseases between co-habitants in water, and the ability to perform 
controlled disease challenge tests on large families of Atlantic salmon, provides us with a convenient model to 
use for investigating genes affecting resistance to this alphavirus, and the knowledge generated using such models 
might provide leads for the treatment or prevention of alphavirus disease in other species.
Globally, six subtypes of SAV virus have been  identified19, each distributed over a specific geographic  range8,20. 
Two subtypes cause outbreaks of PD in Norway: SAV2, mainly affecting farms in the north, and SAV3, mainly 
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in mid and south Norway, with no overlap or co-infection within  sites3,21. Regardless of SAV subtype, internal 
symptoms of the disease include yellow mucoid gut contents or empty intestines, faecal casts, circulatory distur-
bance and petechial haemorrhages in the periacinar  fat22. Histological investigation often reveals complete loss of 
exocrine pancreatic tissue, cardiac myocytic necrosis and inflammation and degeneration and/or inflammation 
of skeletal  muscle23. Real-time reverse transcription-quantitative PCR (RT-qPCR) can be used to diagnose PD, 
identify SAV subtypes and measure relative SAV viral load among  individuals24.
Salmon farmers apply different measures to prevent and control PD outbreaks including vaccination. How-
ever, vaccinations tested using different SAV subtypes show substantial variation in efficacy, suggesting a complex, 
multifactorial basis for  defence12,22,25. The spread of PD mainly occurs through horizontal  transmission8,26,27, 
and vertical transmission has not been convincingly  demonstrated28,29. Hence, restrictions have been applied 
in Norway for the movement of infected fish to avoid spread of PD. However, it is almost impossible to prevent 
transmission of SAV via water currents. In this context, genetic improvement of host resistance through selective 
breeding is a feasible alternative to reduce the impact of the virus on Atlantic salmon production. Resistance 
to PD in Atlantic salmon has been shown to be moderate to highly heritable with estimates ranging from 0.21 
to 0.54 depending on the population used and the model of analysis  applied30,31. Selection methods employing 
molecular tools, i.e. marker assisted selection (MAS) and genomic selection (GS), have been shown to have higher 
accuracy, and result in higher genetic gains than conventional phenotypic selection for traits which cannot be 
directly measured on selection  candidates32, like PD disease resistance. MAS can be more efficient than GS when 
major QTL explaining a large proportion of the genetic variance for the trait have been identified. Gonen et al.31 
reported a QTL for resistance to SAV3 in Atlantic salmon (survival data from both fresh and seawater controlled 
challenge tests and low density SNP genotypes) which showed a strong signal (explaining ~ 23% of within family 
variance for the trait) and consistency across two populations. This QTL for survival against SAV3, located on 
chromosome Ssa03, has been confirmed in Norwegian Mowi AS and Benchmark Genetics Norway AS popula-
tions (Baranski M, Gonen S, Norris A, Hjelmeland R, Sonesson A, Boison S in prep. and Hillestad B, Makvandi-
Nejad S, Krasnov A, Meuwissen T and Moghadam H, in prep. respectively) using intraperitoneal challenge of 
large numbers of nucleus families (150 to 220) genotyped using a 55 K SNP array (personal communication).
Knowledge of the biology of resistance to PD have been revealed by comparing the transcriptome of fish with 
high- and low-genomic breeding values for PD survival at time points before and after challenge with  SAV333. 
Naïve salmon with high genomic breeding values for resistance show a higher expression of genes involved in 
early antiviral responses compared to naïve salmon with relatively low genomic breeding values for PD resist-
ance. Four weeks post-infection, genes involved in the acquired immune response are more highly expressed in 
salmon with high-compared to low-genomic breeding values for PD resistance. Earlier mobilization of acquired 
immunity could accelerate clearance of the pathogen and resolution of the disease.
Viral load and histopathological damage to heart tissue after infection with SAV3 is lower in fish with high- 
than fish with low-genomic breeding values for PD  resistance33. Lower early viral replication has been found 
to be associated with resistance to viral disease in salmonid species e.g. rainbow trout resistance to infectious 
hematopoietic necrosis  virus34. Viral load might be a more economically valuable, accurate and convenient 
measure of resistance or tolerance to PD in the field because mortalities in the field due to PD are often negligible 
(even though hosts carry the virus and shed into the environment) and because animals that are better able to 
resist and clear the SAV infection will be under less stress and more likely to perform better (in terms of growth 
and survival).
In the current study, our two primary aims were to further explore the underlying genetics affecting PD 
resistance in Atlantic salmon and to examine the potential of using SAV3 viral load as an alternative phenotype. 
The experiments in this study therefore explore the genetic basis of resistance against PD using two phenotypes, 
(a) survival (dead/alive) and (b) relative SAV3 viral load measured using RT-qPCR based cycle threshold (Ct) 
values. The specific objectives of the study were to, (i) estimate and compare genetic parameters (heritability, 
genetic correlations) for both traits; (ii) map QTL for SAV viral load and compare to the published QTL for 
survival; (iii) map eQTL in genomic regions significantly associated with resistance to PD; (iv) identify genes 
with potential immune function mapping to the QTL regions that could have functions affecting PD resistance.
Results
challenge test trials. The distribution of mortalities across high and low breeding value (EBV) families 
was described in detail in Robinson et al.33. Twelve percent mortality was observed over the duration of both 
trials with higher mortality in the fish with low genomic estimated breeding value (L-gEBV) than high genomic 
breeding value (H-gEBV) as expected (16.9 and 4.3% mortality in the L- and H-gEBV IP challenge and 20.2 
and 7.1% mortality in the L- and H-gEBV CH challenge groups respectively). Samples for Ct were obtained at 
4 weeks post-infection (W4), which coincided with the highest daily mortality for the cohabitant challenge and 
after the IP challenge had completed the highest mortality period. Samples were also obtained at 10 weeks post-
infection (W10). W4 IP animals had a lower viral load than CH animals (Table 1), which was expected consider-
ing that IP tested fish survived the steepest part of the mortality curve. The IP trial would therefore be expected 
to be less powerful for detecting QTL as viral titre was generally lower in IP than CH challenged fish, and as the 
most susceptible fish in the L-gEBV group would have died prior to viral load measurement (and therefore are 
not in the analysis). IP fish also presented lower viral loads at W10 by which stage the virus would have been 
substantially cleared in some animals (Table 1). Viral loads were lower at W10 than at W4 for both challenge 
models which is likely to be because the immune system has responded and substantially cleared the virus by 
W10 and because the most susceptible animals would have succumbed to the disease and died by W10 (Table 1). 
No mortalities were observed in the control group of uninfected fish.
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Genomics based variance components. Overall, genomic heritability for resistance to SAV3 ranged 
from 0.15 to 0.74 depending on challenge type and trait (Table 2). Higher genomic heritability was detected for 
the CH trial and for the dead or alive survival trait (PDA) than for the IP trial and Ct trait respectively. Genetic 
correlations computed between PDA and Ct using the bivariate model ranged from 0.91(SE 0.28) to 0.98(SE 0.05) 
for IP and CH respectively and also varied with data type ( Ct and PDA traits analyzed separately for CH and IP 
or all together). The genetic correlation for Ct values between IP and CH was 0.73 (SE 0.20, Table 3). The genetic 
correlation of Ct values between sampling times (W4 and W10) was moderate for CH (0.58 ± 0.35) and high for 
the IP challenge model (0.99 ± 0.26, Table 3).
Genome wide association analysis. GWAS analysis of the salmonid alpha virus RT-qPCR Ct-value trait 
detected likely genome-wide QTL positioned on Ssa03. Two SNPs showed significant association (chromosome-
wide significance) with relative SAV viral load for the analysis of W4 individuals in the IP test (Table 4, Fig. 1C), 
and 15 SNPs around the same region had chromosome- or genome-wide Bonferroni corrected significance for 
the analysis of individuals in the CH test (Table 4, Fig. 1A). No evidence for multiple QTL was found when the 
top-most significant marker was fitted as a covariant in the analysis, even though the SNPs of genome-wide 
significance mapped to a broad region of Ssa03. The estimated size of the QTL effect (percentage of the genetic 
variation explained) for the top most significant SNPs at position 63 Mb (CH) and 83 Mb (IP) was 34.7 and 
48.6% respectively. The λ value (magnitude of the deviation inflation/deflation of p-values) for the analysis was 
1.21 (distribution of p-values presented as a Q–Q plot in Supplemental Fig. S1).
The map position for the QTL for relative SAV viral load detected on Ssa03 was unclear but the area contain-
ing SNPs significantly associated with Ct covered the same positions as for genome- and chromosome-wide 
associations detected for PDA (eight SNPs positioned between 75–83 Mb and three between 89–91 Mb) and the 
position detected by Gonen et al.31 for survival to IP challenge, strongly suggesting that both are caused by the 
Table 1.  Summary of SAV RT-qPCR cycle threshold  (Ct) results. Ct is negatively related to relative viral load. 
Salmon with high or low estimated genomic breeding values (H or L gEBV group respectively) were infected 
for the challenge test trials by intraperitoneal injection (IP) or cohabitation with infected fish (CH). Testing 
occurred 4 weeks post-infection (W4) and 10 weeks post-infection (W10).
Sampling time Challenge type EBV group n Mean SD Minimum Maximum
W4 CH H 141 17.99 2.01 11.96 24.48
W4 CH L 125 17.47 1.66 12.58 23.20
W4 IP H 140 23.28 2.08 17.02 30.16
W4 IP L 116 22.65 2.18 17.32 30.32
W10 CH H 122 27.50 2.02 22.47 38.09
W10 CH L 85 26.53 1.51 22.80 33.21
W10 IP H 131 29.98 3.15 24.63 39.23
W10 IP L 107 29.99 3.52 18.68 39.89
Table 2.  Heritability estimates for survival (dead or alive, PDA ) and relative SAV3 viral load (SAV3 RT-qPCR 
cycle threshold, Ct ) phenotypes at W4. Salmon were infected for the challenge test trials by intraperitoneal 
injection (IP) or cohabitation with infected fish (CH). Standard errors in parentheses.
Traits
h
2
IP CH
PDA 0.40 (0.13) 0.74 (0.08)
Ct 0.15 (0.06) 0.21 (0.07)
Table 3.  Genetic correlations for relative SAV3 viral load (SAV3 RT-qPCR cycle threshold,  Ct) between 
sampling times (W4 and W10) and across and within challenge types. Standard errors in parentheses. IP 
intraperitoneal injection, CH cohabitation with infected fish.
Comparison Correlation (standard error)
W4 vs. W10 (CH) 0.58 (0.35)
W4 vs. W10 (IP) 0.99 (0.26)
CH vs. IP 0.73 (0.20)
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same underlying gene(s). This conclusion is supported by the high correlation of Ct and PDA traits found in this 
study (close to 1.0).
IGH and B cell-specific genes. The region containing SNPs associated with the SAV viral load includes 
locus B of Atlantic salmon immunoglobulin heavy chain (IGH). Reference sequences of the constant regions 
of all three types of immunoglobulins (IgM, IgT and IgD) and multiple VH, D and J segments of the variable 
region retrieved from The International Immunogenetics Information  System35 (https ://www.imgt.org/), 106 
sequences in total, map between 77.5 and 79,3 Mb (Fig. 2). A short 258-Kb region between 76.4–76.5 contains 
four genes with important roles in B cells. cd22 has been found to regulate B-cell receptors in mammals prevent-
ing excessive activity and autoimmune  reactions36. Strong responses of multiple cd22 paralogs to vaccination 
have been shown in Atlantic  salmon37. Three other genes located in the same area belong to the TNF receptor 
family that controls all aspects of B-cell development and  function38. Genes mapping between 76.3–77.0 Mb 
are similar to TNF receptor type 16, which is also known as ngfr—receptor of nerve growth factor. Human 
NGFR was reported to rescue B lymphocytes from  apoptosis39, but the precise role of these genes in salmon is 
unknown. Overall, a 2.8 Mb region on Ssa03 contains 87 genes in addition to the IGH segments (Fig. 2). Four 
genes from the B-cell signalling pathway (ras-related c3 botulinum toxin substrate 1, gtpase hras, grb2-related 
adapter protein and serine/threonine-protein kinase smg1) map between 80 and 92 Mb.
Characterization of SNPs and genes mapping to the distal end of Ssa03. We undertook a more 
detailed investigation of the variants and genes mapping to a region between 88 and 93 Mb towards the end 
of Ssa03 which included the three most distally occurring chromosome and genome-wide associated Ct QTL 
SNP loci, and encompassed the most likely QTL position estimated by Gonen et al.31 and a likely QTL posi-
tion estimated from yet unpublished studies of the Mowi AS and Benchmark Genetics Norway AS populations 
(Baranski M, Gonen S, Norris A, Hjelmeland R, Sonesson A, Boison S in prep. and Hillestad B, Makvandi-Nejad 
S, Krasnov A, Meuwissen T and Moghadam H, in prep. respectively) for PD survival (88–93 Mb toward the end 
of Ssa03, Fig. 1C).
Ninety-eight genes mapped to this 88–93 Mb region on Ssa03. Several of these genes are known or are pre-
dicted to have immune functions (Table 5, Fig. 3). The SNP with genome-wide association with Ct in this region 
(AX-88234566 at position 89963083) maps to the 3′ untranslated region of grass carp reovirus-induced gene 1 
(gig1), a member of a multigene family of antiviral effectors found only in  fish40. Rsad1 or viperin destroys lipid 
rafts preventing budding and release of  viruses41. Atlantic salmon gig1 and viperin strongly respond to viral 
infections in  salmon42,43. Tlr13 is a putative ortholog of mammalian pathogen recognition receptor binding 
bacterial  RNA44. Proteins with NACHT, LRR and PYD domains can be involved in diverse processes including 
pathogen recognition and  inflammation45,46. Mbl12 may activate the lectin complement pathway. Several genes 
mapping to this region of Ssa03 were differentially expressed between H- and L-gEBV fish at stages before and/
or after infection. Tlr13 was up-regulated in H-gEBV relative to L-gEBV in naïve fish and at 4 weeks post infec-
tion, and down-regulated in H-gEBV relative to L-gEBV fish 10 weeks post infection. Gig1-like was significantly 
Table 4.  SNPs with genome- and chromosome-wide significant associations with relative SAV viral load in 
CH and IP trials. Pos (bp) physical position of SNP in base pairs, A1 & A2 minor & major alleles, respectively, 
MAF minor allele frequency, α Allele substitution effect, SE standard error, P significance value.
CHR SNP Pos (bp) A1 A2 MAF α SE P-value
CH
3 AX-87986229 26488333 A C 0.34 − 0.74 0.17 7.43E−06
3 AX-87865538 30994059 A G 0.34 − 0.72 0.16 1.2E−05
3 AX-96308943 31004919 C T 0.37 − 0.74 0.16 2.63E−06
3 AX-87618835 34527144 T C 0.27 − 0.74 0.17 9.06E−06
3 AX-87849339 63236952 G A 0.49 0.83 0.16 1.28E−07
3 AX-96264043 76082530 C A 0.30 − 0.73 0.16 3.36E−06
3 AX-96455227 76082537 C A 0.30 − 0.74 0.16 2.48E−06
3 AX-88146078 77489246 A G 0.22 − 0.78 0.19 2.51E−05
3 AX-88163075 8678000 T C 0.17 − 0.88 0.21 2.66E−05
3 AX-98305314 82718110 G T 0.30 − 0.68 0.16 1.99E−05
3 AX-88293328 83391111 T C 0.49 0.85 0.16 1.94E−07
3 AX-88010358 84875109 C T 0.36 − 0.63 0.15 2.44E−05
3 AX-96235336 89833309 A G 0.47 0.69 0.15 4.58E−06
3 AX-88234566 89963083 C T 0.48 0.83 0.16 4.1E−07
3 AX-88122450 90830375 C G 0.39 0.58 0.13 7.96E−06
IP
3 AX-87885147 81776059 A C 0.21 − 1.20 0.26 5.33E−06
3 AX-88130071 82718000 C T 0.19 − 1.22 0.28 1.07E−05
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Figure 1.  Manhattan plots of GWAS p-values for relative SAV3 viral load (− Ct) distributed across all 
chromosomes and for positions across Ssa03. Markers crossing genome and/or chromosome wide Bonferroni 
threshold are dotted in green colour. Results from the CH challenge trial (A, C) and the IP trial (B, D) are 
shown for SNPs on all chromosomes (A, B) and for SNPs on Ssa03 (C, D).
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down-regulated in expression in H-gEBV compared to L-gEBV fish at 4 weeks post-IP-infection (Fig. 4). The 
regulation of expression of gig1 was positively correlated with viral load over all treatment groups and over all 
weeks (Pearson’s  r2 = 0.73, P < 0.01). This reflects the differences in expression and viral load over the weeks as no 
significant correlations were found within W0, W4 or W10 (both viral load and level of gene expression starts 
low at W0, becomes relatively higher at W4 and falls back to low levels by W10). Table 5 also shows differentially 
expressed genes with metabolic and developmental roles.
Eighty-three missense mutations, 1 lost stop codon in putative oxidoreductase (glyr1) and 1 premature stop 
codon in tripartite motif-containing protein 16 (trim16) were detected. Missense mutations were detected in 
several genes of interest, i.e. two in genes affecting pathogen recognition and inflammation (nlrp4 and nlrp12), 
1 toll-like receptor (tlr13), 1 ubiquitin peptidase that interacts with herpes virus (usp7), 2 lectins (c-type lectin , 
clec19a, and mannose-binding protein C, mbl2, the latter of which activates the lectin complement pathway), 3 
genes involved in methylation (mettl22, suz12 and glyr1) and 1 gene inhibiting apoptosis through casp9 (arl6ip1).
eQtL. Two potential eQTL of interest were detected on Ssa03, one which was marked by SNP AX-88225911 
at position 89781579 and associated with 492 genes (p-value < 0.01), and another eQTL which was marked by 
two SNPs (AX-98325256 at position 904438097 and AX-98325250 at position 90438576) and associated with 
68 genes (Fig. 3 and Supplemental Tables S1, S2, and S3). The former (AX-88225911) showed the highest asso-
Figure 2.  Histograms showing counts of sequences of IGH locus mapping across Ssa03 (positions in Mega base 
pairs, Mbp). Location of immune genes and SNPs significantly associated with  Ct (red asterisks) are indicated.
Table 5.  Highlighted immune genes mapping to 88–93 Mb QTL region on Ssa03. Start and end map positions 
for each gene are shown (bp). Differentially expressed genes are marked with *.
Gene name Position
C-type lectin domain family 19, member A (clec19a) 88422047–88426187
Radical S-adenosyl methionine domain-containing protein 1, mitochondrial-like (rsad1) 88965135–88966658
NACHT, LRR and PYD domains (nlrp12-like) 89494115–89508816
NACHT, LRR and PYD domains (nlrp4e-like) 89871181–89874262
Grass Carp Reovirus-Induced gene 1 (Gig1-like)* 89962846–89966991
Mannose-binding protein C-like (mbl2-like)* 90310449–90311598
Toll-like receptor 13 (tlr13)* 90560925–90564725
NACHT, LRR and PYD domains (nlrp12-like)* 91446779–91461776
NACHT, LRR and PYD domains (sntx subunit beta) 91655995–91658466
NACHT, LRR and PYD domains (sntx subunit beta) 91689071–91695362
Putative oxidoreductase GLYR1 (glyr1)* 89116660–89121529
Chloride channel-2C voltage-sensitive 7 (clcn7)* 89555699–89613839
Meteorin, glial cell differentiation regulator* 90812513–90828352
Tubulin-specific chaperone D (tbcd)* 90860420–90875441
4-aminobutyrate aminotransferase (abat)* 89433950–89493945
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ciation with an ubiquitin-like protein and a probable E3 ubiquitin-protein ligase RNF144A-A; several other 
ubiquitin-related genes showed nominal association (E3 ubiquitin-protein ligase SMURF2, E3 ubiquitin-protein 
ligase AMFR, or ubiquitin-conjugating enzyme E2 variant 1), and other immune genes such as major histocom-
patibility complex class I-related gene, interleukin-4 receptor alpha chain, tumor necrosis factor receptor super-
family member 1B or C–C motif chemokine 19. The latter eQTL (AX-98325256 and AX-98325250) showed 
FDR-corrected significant association with the stonustoxin subunit beta-like gene (sntx beta-like). A gene also 
annotated as sntx beta-like mapped to around 91.6 Mb along Ssa03 less than 1 Mb from SNP AX-88122450 
which was significantly associated with relative SAV viral load (Supplemental Tables S1, S3, Fig. 3). Sntx beta-like 
was more highly expressed in H-gEBV than L-g-EBV fish 4 weeks post-infection in the CH trial.
Discussion
clearance and resistance to initial infection. This study is the first comparison of viral load and sur-
vival genetic parameters for a fish species. Mortality due to PD is often negligible, but the disease severely affects 
growth, feed conversion and meat  quality47. Animals able to restrict viral load are likely to be less stressed, grow 
faster and produce a higher quality product. Furthermore, infected salmon that survive but carry high viral loads 
probably have a greater influence on the spread and impact of disease outbreaks than other survivors with lower 
relative SAV viral load. Relative SAV viral load (Ct) measures the ability to resist the initial SAV infection and 
clear the virus and holds promise as a more relevant trait for genomic selection to improve resistance to pan-
creas disease than the ability to survive infection as measured by PDA. Despite Ct having a lower heritability than 
PDA, the two traits were found to be highly correlated, and the same QTL region at the proximal end of Ssa03 
was found to be associated with both traits. Together with our previous reported finding of lower viral load in 
H-gEBV  fish33, this confirms expectations that survival is at least partly dependent on the ability to resist and 
clear the virus. Tests of viral load therefore have potential application for assessing the relative resistance of fish 
Figure 3.  Map of the 88–93 Mb QTL region on Ssa03 showing Manhattan plot and genes that are differentially 
expressed in H-gEBV versus L-gEBV salmon (highlighted as red text) and trans-eQTL (highlighted in green 
text). SNP AX-88234566 at position 89963083 which was associated with relative SAV3 viral load (genome wide 
significance) mapped to a 3′UTR region of gig1 (highlighted in orange). The other two SNPs associated with 
relative SAV3 viral load mapped to intergenic regions (relative positions indicated by arrows).
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even in the absence of significant mortality caused by pancreas disease. Animals able to restrict viral replication 
are likely to be less stressed, grow faster and produce a higher quality product.
Fish with PD survive due to either clearance of the virus or ability to tolerate the pathogen. Measurement of 
viral load enables discrimination of survivors that could become carriers and spread  infection48–50. Breeding for 
low viral load would select individuals that mount an active defense to clear the virus and would therefore be a 
more attractive strategy than breeding for survival. Mapping of Ct and PDA QTL to the same position suggests 
that defence is of paramount importance. The difference between the CH and IP models is likely to reflect the 
greater complexity of the processes involved in the CH trial, since water borne pathogen encounters barrier tissue 
(skin, gill and intestine) and mucosal  immunity44. Slower and more natural development of the disease with the 
CH challenge would also provide greater scope for mounting acquired immune responses. This may explain the 
detection of more SNPs significantly associated with Ct on Ssa03, and the suggestion of additional QTL peaks on 
Ssa03 for the CH trial compared to the IP trial. However, these differences can also be at least partly accounted 
for by the design of experiment. Sampling for the measurement of Ct at 4 weeks post infection occurred as the 
CH trial underwent and the IP trial finished the steepest phase of the mortality curve. In this way the SAV RT-
qPCR Ct measurements gave a snapshot of relative SAV viral load at different phases of infection in the CH and 
IP trial animals. We would expect that the greater difference between salmon with high and low resistance at the 
peak of disease could also lead to the greater sensitivity of the CH compared to IP trials for detecting Ct QTL.
Gonen et al.31 found evidence that similar genetic mechanisms affect resistance to PD in fry and post-smolt, 
post-smolt being the stage usually affected by natural outbreaks of PD. Therefore, it seems likely that the QTL 
associated with resistance and clearance of the virus in freshwater will also be responsible for resistance and 
clearance of the pathogen in saltwater at later life stages. PDA heritability for the IP challenge test in our study 
was greater than that found by Norris et al.30 for mortality data recorded after an outbreak of the disease in the 
Figure 4.  Boxplot of changes in expression of grass carp reovirus-induced gene 1 (Gig1-like), mapping to 
approximately 90.0 Mb along Ssa03. Plots show count of fragments per kilobase million (FPKM) for H-gEBV 
(green dot) and L-gEBV (red dot) fish challenged by intraperitoneal injection (IP) or cohabitation (CH) and 
sampled at 0- (naïve), 4- or 10-weeks post-infection.
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sea, but similar to that found by Gonen et al.31 in post-smolt salmon that were experimentally challenged by IP 
injection (using similar methodology to that presented here).
candidate genes of immune function mapping to QtL. Twelve chromosome- or genome-wide viral 
load associated SNPs mapped to the distal end of Ssa03 from 76 Mb onwards. This broad region containing 
SNPs associated with PD resistance corresponds with the findings of the unpublished studies by Mowi AS and 
Benchmark Genetics Norway AS (Baranski M, Gonen S, Norris A, Hjelmeland R, Sonesson A, Boison S in 
prep. and Hillestad B, Makvandi-Nejad S, Krasnov A, Meuwissen T and Moghadam H, in prep. respectively), 
which were able to differentiate the presence of two QTL, QTL1 mapping to 88–93 Mb, and QTL2 mapping to 
73–78 Mb. Given the pivotal role of active defence for resistance against PD, the immune genes in this area are 
of special interest. The region of QTL2 begins with several B cell-specific genes and the IGH locus. Studies of 
transcriptome responses of Atlantic salmon to viral infections have suggested that acquired humoral immunity 
is of key importance for resistance against viral diseases. Increased expression of ig in the heart and spleen was 
identified as the main factor explaining longer survival in fish challenged with Infectious Salmon Anaemia—
ISA51. Recovery from Heart and Skeletal Muscle Inflammation (HSMI) and PD occurs shortly after marked 
increase of ig transcripts in the infected  sites43. The association of the immunoglobulin locus with the viral load 
QTL is supported by our findings of higher expression of ig light chain in H-gEBV than L-gEBV fish and our 
finding of higher activity of several genes associated with the recruitment of B-cells nuclear gtpase slip-gc52, 
 cd2236, in H-gEBV fish at 4 weeks post-SAV  infection33. The genomic regions encoding IGH were identified as 
duplicated loci by Yakuike et al.53 and IGH maps to this region of Ssa03 and to an area of Ssa06 in the Atlantic 
salmon  genome54. Publications in preparation (Hillestad B, Makvandi-Nejad S, Krasnov A, Meuwissen T and 
Moghadam H, in prep.) show that the 10 most genome-wide significant SNPs in the QTL2 region (P < 4.0E−20) 
map to 73–78 Mb which encompasses at least part of the same region containing IGH-B, which, according to 
our estimates, produces about 70% of all  antibodies55. IGH-B includes multiple exons encoding the constant 
regions of IgM, IgT and IgD, 28 D (diversity) genes, eight JH (junction) genes and multiple VH (variable) genes 
of which 36 are  functional56. In each B cell, the IGH locus encodes a single heavy chain produced by somatic 
recombination of four genes (CH, JH, D and V) followed with diversification—enzymatic addition and deletion 
of nucleotides. Mutations in the IGH-B locus may affect the amounts and properties of antibodies (recognition 
of pathogens and affinity) and the composition of the antibody repertoire.
The clearest positional information for the QTL1 was for the Mowi unpublished study (which had the largest 
set of families and SNPs, Baranski M, Gonen S, Norris A, Hjelmeland R, Sonesson A, Boison S in prep.) where 
the PDA QTL1 mapped to between 88 and 93 Mb towards the end of Ssa03. Both the Ct and PDA QTL are likely 
to be caused by the same underlying gene(s) given the high genetic correlation (nearly 1.0) detected between 
the traits in our study. Therefore, we also focussed our search for functionally relevant candidate immune genes 
and eQTL to the region where QTL1 was positioned in this unpublished study.
The region between 88 and 93 Mb towards the end of Ssa03 contained genes, that bind to foreign organisms 
and activate the complement pathway, such as pattern recognition c-type lectins mbl2-like which binds man-
nose, fucose and N-acetylglucosamine (e.g. binds to mannose glycans on  HIV57), activates the lectin complement 
pathway and enhances engulfment by  phagocytes58,59, and clec19a which adheres to pathogen infected cells 
and is involved in  apoptosis60. Other genes mapping in the region (or affected by SNPs in the region) included 
tlr13 which is expressed in macrophages and recognises conserved molecules expressed by  viruses61 and other 
microbes, sntx subunit beta-like which may be a member of the membrane attack complex destroying infected 
 cells62, grb2-like involved in T-cell specific protein tyrosine kinase and mannose receptor  signalling63,64, nlrp12-
like could be a negative regulator of the innate immune  response65 and plays a role in mediating viral inflamma-
tory  responses66 and gig1-like which is an antiviral  effector40.
QtL and nature of genetic resistance to pD. The QTL detected account for a large proportion of the 
genetic variance for the  Ct trait. However, the estimation of effect size is likely to be upwardly biased in our 
experiment because high- and low-ranking families for PD resistance were studied, which in effect resulted in 
a form of selective genotyping for GWAS. Most genetic studies assume that QTL of large effect (in the extreme 
case, when a single locus is responsible for nearly all of the genetic variation in the trait) are caused by the 
inheritance of two, or a few, alternative alleles of a single gene (e.g. one or a few causative single nucleotide poly-
morphisms or indels). However, the hypervariable and multi-element nature of the IGH locus presents us with 
a quite different scenario, one which might explain why the strength of association and positioning of QTL2 on 
Ssa03 has been found to vary depending on population and challenge test event studied.
Antibodies are assembled using different combinations of these hypervariable elements. These antibodies 
recognise viral antigens and set the immune response in process. The hypervariability provided by multiple 
combinations of elements, and diversification with enzymatic addition and deletion of nucleotides, is needed 
because infectious organisms like SAV quickly mutate and change, and the immune system of vertebrates needs 
to be able to present antibodies that can recognise new strains and forms of pathogens as they arise. The IGH-B 
locus is characterized by its large size and extreme complexity, and several immune genes, including genes with 
key roles in B cells, map to the same region as IGH-B. The variants in the multiple elements of IGH-B may have 
additive effects on the resistance afforded by the locus.
This rapidly evolving and complex interaction between the virus and the IGH locus might explain why the 
SNPs in genome-wide association with relative viral load (Ct) map broadly to positions from 63 to 90 Mb across 
Ssa03 in our and the other studies and why the strength of association for the second QTL peak at 73–78 Mb 
varies depending on the salmon population studied and challenge test occasion (presumably using different 
viral homogenates or isolates)31 (and unpublished data from Mowi AS and Benchmark Genetics Norway AS : 
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Baranski M, Gonen S, Norris A, Hjelmeland R, Sonesson A, Boison S in prep. and Hillestad B, Makvandi-Nejad 
S, Krasnov A, Meuwissen T and Moghadam H in prep. respectively).
Breeding to select entire haplotypes with preferable combinations of IGH-B variants could achieve rapid 
genetic improvement in resistance in the short-term. But breeding to promote diversity at the locus should also be 
considered because selection to fix variation at one element would also fix variation at closely mapping elements 
in LD. By utilising gene editing it might be possible to create specific IGH-B elements that give the individual high 
resistance to current strains of the PD virus while maintaining diversity among other nearby mapping elements. 
In the future it could become feasible to sequence prevalent strains of virus and predict what IGH-B variants 
would be most effective and should be created using gene editing as a gene therapy.
On-the-other-hand, the position of the other more pronounced and consistent QTL1 peak close to the end 
of Ssa03 could indicate the involvement of one or a few genes and a simpler underlying biological explanation 
for the effect on resistance at this position. Further studies are needed to determine if and to what extent these 
two QTL interact to effect resistance, precisely what variants are involved and how breeding strategies should be 
formulated. The hypervariable multi-element nature of the IGH locus might necessitate the adoption of novel 
approaches for these further investigations.
conclusion
Heart salmonid alphavirus load at 4 weeks post infection is heritable and highly correlated with survival (dead or 
alive) and is therefore a good indicator of pancreas disease resistance in Atlantic salmon. Viral load after cohabit-
ant challenge tests accounts for a broader range of defence mechanisms, and is more sensitive for the detection of 
QTL, than viral load after intraperitoneal challenge. The QTL detected on Ssa03 for the viral load trait are likely 
the same as those detected for survival. The two QTL explained a high proportion of the total genetic variance for 
the trait. A suite of immune genes with potential effects on resistance map in the vicinity of the QTL including the 
multi-gene IGH-B locus, cd22-like, c-type lectins mbl2-like and clec19a, tlr13, sntx subunit beta-like, grb2-like, 
nlrp12-like and gig1-like, and SNPs acting as trans-eQTL on genes of other chromosomes including sntx subunit 
beta-like. It is possible that the causative variant(s) on Ssa03 affects the expression of multiple immune genes in 
cis- and trans-association. The study represents the most comprehensive search for candidate genes mapping to 
the region of the salmonid alphavirus load/pancreas disease resistance QTL to date and has contributed useful 
insights about the biology of resistance to viral diseases in salmon.
Methods
Resource population. A population comprising 10 full-sib families (~ 110 fish per family) originating 
from the breeding nucleus of Benchmark Genetics Norway AS was used for the current study (as described 
 by33). Out of these 10 families, 5 were produced from parents which ranked high and 5 were from parents that 
ranked low for resistance (measured as the probability of being dead or alive,  PDA, with an intraperitoneal chal-
lenge test against SAV3 with point deviation from mean genomic breeding value, gEBV, of + 27.3% and − 14.3% 
for the high- and low- families respectively).
challenge test. Atlantic salmon were challenged with SAV3 using two models, cohabitation (CH) infec-
tion and intraperitoneal (IP) injection as described  previously33. Parr stage fish (average weight of ~ 30 g) tagged 
with passive integrated transponders (PIT-tags, parentage recorded) were split into two groups by randomly 
sampling ~ 50 individuals per family. Parr in the replicate tanks were acclimatized for ~ 20 days before being 
challenged. Half the parr in each tank were anaesthetized and challenged by intraperitoneal injection with 0.1 ml 
of SAV3 suspension (isolate VESO Vikan Jnr. 2,333 at 2.5 × 107 virus/ml). PIT tags of these fish were scanned, 
and these animals recorded as the (IP group). The remaining fish from each tank were anesthetised, PIT tag 
recorded and transferred to the same tank as the IP group fish. These fish were recorded as cohabitants with the 
IP infected fish (CH group fish) and the IP infected fish in this way acted as shedders of the SAV virus for the 
cohabitant challenge. The environmental conditions including feeding, nutrition, water temperature and salinity 
were therefore uniform across the different challenge tests (common garden experiment). Mortalities, PIT tag 
number and date were recorded daily. The total duration of the challenge experiment was 10 weeks. Adipose fin 
clips were sampled after 4 weeks post-challenge from all animals and preserved in 85% ethanol for DNA extrac-
tion for SNP genotyping.
All challenge testing procedures were performed by VESO Vikan in a secure containment facility in Nam-
sos Norway using standard operating procedures as approved by the Norwegian Animal Research Authority, 
National Assignments Department (approval no. 8841). Both challenges were conducted in accordance with the 
laws and regulations controlling experiments and procedures for live animals in Norway (the Animal Welfare 
Act of December 20th, 1974, No 73, chapter VI sections 20–22 and the Regulation on Animal Experimentation 
of January 15th, 1996).
DNA extraction and genotyping. Genomic DNA was extracted from the fin clips using a commercial kit 
(DNeasy Blood & Tissue Kit, Qiagen), following the manufacturer’s instructions. All individuals (n ~ 1,100) were 
genotyped using a ~ 55 K axiom Affymetrix SNP Genotyping Array (NOFSAL03).
Genotypic data was filtered using the Plink  software67 excluding SNPs with minor allele frequency (MAF) 
lower than 5%, missing more than 15% of genotypes, and/or with one or more Mendelian inheritance error. 
Approximately 54 K SNPs were retained for downstream analyses.
Sampling for RT-qPCR. Samples were collected at three different time points: (i) the day before challenge 
with SAV3 at which stage fish were naïve to the virus (designated week 0 of the challenge trial, W0), (ii) at week 
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4 (W4) and (iii) at week 10 (W10) of the SAV3 challenge trial. Fish from each family and challenge model were 
randomly chosen and sacrificed at these time points to acquire heart tissue samples for SAV3 RT-qPCR. Heart 
ventricle is severely damaged during SAV3 viral infection (more severely than pancreas tissue) and heart damage 
is routinely assessed as an indicator of the severity of the  disease7,11,23. Samples were preserved in RNAlater (per 
manufacturer’s specifications, Ambion). Samples from fish dying during the challenge trial before the sampling 
time points were not used for RT-qPCR. The number of samples used for SAV3 RT-qPCR and mRNA-seq is 
shown in Table 6.
RNA extraction and RT-qPCR. RNA isolation and quantification were performed as described 
 previously33. The RT-qPCR was performed in duplicate using a QuantStudio 5 instrument (Applied Biosystems, 
Thermo Fisher Scientific). The 20µL total volume reactions consisted of 10µL Power SYBR Green PCR Master 
Mix (Applied Biosystems), 0.6 µL 10 µM forward and reverse primers, 8 µL 1:40 diluted cDNA. The cycling 
profile was 2 min at 50 °C and 10 min at 95 °C, followed by 40 cycles at 95 °C for 15 s and 60 °C for 60 s. A 
no-template (water) control was included and a melting curve analysis was performed to verify the measure-
ment of a single specific product. QuantStudio Design & Analysis Software (Applied Biosystems, Thermo Fisher 
Scientific) was used for data collection and analysis of cycle threshold (Ct) values. Primers used for RT-qPCR 
of salmonid alphavirus were as follows: forward CCG GCC CTG AAC CAGTT and reverse GTA GCC AAG TGG 
GAG AAA GCT 24. Results are presented as—Ct normalized by RNA concentration.
phenotypes. At the end of lab-based analysis and the challenge tests, two phenotypic records were obtained 
as a measure of resistance against SAV3, survival status (dead/alive, PDA ) and Ct values representing viral load. 
Individuals that survived until W10 were considered to be survivors.
Statistical analyses. The heritability of PDA and Ct were estimated by ASReml 4.068 using a genomic ( G ) 
relationship matrix with the following linear mixed model:
where y is a vector of ‘n’ records on PDA and/or Ct values, µ is an overall mean, u is a vector of additive genetic 
effects distributed as u ∼ N
(
0,Gσ 2u
)
, where σ 2u  is the additive genetic variance, G is a genomic relationship 
matrix; Z is the corresponding incidence matrix to additive effects, and e is the vector of random residual effects 
with e ∼ N(0, Iσ 2e) . The genomic relationship matrix was constructed using the  VanRaden69 method as 
ZZ
′
2∗
∑Nsnp
i=1 pi(1−pi)
; where pi is the allele frequency of second allele and Nsnp is the total number of SNP markers. Z 
is a centered genotype matrix which is equal to mji − 2pi ; where mji is the genotype of marker i on animal j . The 
marker genotypes are coded as 0, 1 and 2 representing the homozygote for the first allele, heterozygote, and the 
homozygote for the second allele, respectively. Heritability (narrow sense) was estimated as the ratio of additive 
genetic variance to total phenotypic variance by running univariate analyses.
The data was analysed separately for each challenge test as well as collectively including information from 
both challenge tests. In the collective analysis, challenge model type (IP and CH) was fitted as a fixed effect. 
Bivariate analysis including both phenotypes in the model was run to determine the genetic correlation between 
PDA and Ct using full dataset (W4 and W10 sampling) covering each of the challenge condition (CH and IP).
Genome-wide association analysis (GWAS). A genome wide association analysis was performed using 
a linear mixed model equation on both PDA (binary trait) and Ct values at W4. However, in this manuscript 
GWAS results will focus mainly on Ct values because the aim of this study was to evaluate Ct as a trait for test-
ing and selection. Hence, GWAS analysis was performed on Ct values obtained on IP tested individuals and 
CH tested individuals separately. The model applied for GWAS was the same as described above, however an 
additional variable was added to estimate marker effects. The GCTA  program70 with “-mlma-loco” function was 
used to detect marker ~ trait associations. This approach estimated SNP effects by accounting for additive genetic 
variance captured by all the markers at chromosomes other than the SNP containing chromosome.
SNPs were considered genome wide significant when they exceeded the Bonferroni threshold for multiple 
testing (alpha = 0.05) of 0.05/tg , where tg = 54,282 (total number of SNPs genome-wide) and graded as chro-
mosome-wide significant when Bonferroni threshold for multiple testing surpassed (alpha = 0.05) of 0.05/tc , 
y = µ+ Zu+ e,
Table 6.  Numbers of animals sampled for SAV3 RT-qPCR. Numbers of samples used for mRNA-seq in 
parentheses. Salmon with high or low estimated genomic breeding values (gEBV) were infected for the 
challenge test trials by intraperitoneal injection (IP) or cohabitation with infected fish (CH). Testing occurred 
one day before infection (W0), 4 weeks post-infection (W4) or 10 weeks post-infection (W10).
gEBV Challenge model Naïve (W0) W4 W10
High
IP 67 (15) 140 (5) 140 (5)
CH 141 (5) 123 (5)
Low
IP 68 (15) 116 (5) 109 (5)
CH 125 (5) 85 (5)
Total 135 (30) 522 (20) 457 (20)
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where tc = 1,871 (average number of SNPs per chromosome). The genome-wide significant threshold used in this 
study was considered to be P ≤ 9.21× 10−7 which is equivalent to −log
10
(P) = 6.04 , while chromosome-wide 
significant threshold was P ≤ 2.67× 10−5 which is equal to −log
10
(P) = 4.57
The distribution of observed vs. expected p-values was plotted as a quantile–quantile (q–q plot) plot, and the 
inflation factor (lambda, λ) was calculated using following equation
The proportion of variance explained by the top SNPs (VarSNP) was estimated as
where pi is the observed allele frequency for the first allele, qi is the allele frequency of the alternative allele and 
α2i  is the square of the marker effect for the ith SNP  marker71.
Further SNP detection using mRNA-seq data. Additional SNPs for eQTL detection were identified 
from the RNA sequencing data using samtools v1.6  software72 and genotypes for these additional SNPs were 
obtained from the RNA sequences of individual samples. PCR duplicates, reads with mapping quality < 20 and 
bases with phred quality scores < 20 were excluded from analysis. SNPs occurring within 5 bp of an indel, with 
quality < 20, MAF < 0.10 or less than 4 reads supporting the alternative allele were discarded. SNPs were anno-
tated using SNPeff  software73.
Differential gene expression and eQTL detection. The differential expression of genes mapping to 
the QTL regions was assessed by mRNA-seq at time points W0, W4 and W10 using data and methods described 
 by33 for a subset of the animals that were genotyped (Table 6). In short, mRNA-seq was performed on an Illu-
mina HiSeq 3000 platform (6 lanes for the 70 libraries and 150 bp paired-end reads).
Gene expression FPKM values were used for the expression-QTL (eQTL) analysis, considering only those 
genes showing FPKM > 5 in any of the experimental groups. SNP genotype data (from the NOFSAL3 SNP 
array and from mRNA-seq identified SNPs) were used. The eQTL analysis was performed using R/MatrixEQTL 
v2.2.74. Two variables, time point of sampling and challenge test model, were fitted as covariates in the model 
for analysis. The effect of a SNP on gene expression was considered to be in cis if the distance between gene and 
SNP was < 500 kb. eQTL associations showing FDR corrected p-values < 0.05 were considered significant. For 
those SNPs showing at least one significant trans-eQTL (FDR p-value < 0.05) further SNP—gene expression 
associations were considered using a relaxed nominal p-value threshold of 0.01.
Data availability
All raw and processed sequence data generated in this study have been deposited in the NCBI Short Read 
Archive (https ://www.ncbi.nlm.nih.gov/sra) under BioProject ID PRJNA543940. GWAS summary statistics data 
is available in Table 4.
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